Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 29 studies | 39% ± 17% | |
smooth muscle cell | 21 studies | 33% ± 13% | |
fibroblast | 15 studies | 26% ± 7% | |
myofibroblast cell | 9 studies | 31% ± 12% | |
endothelial cell | 6 studies | 28% ± 13% | |
connective tissue cell | 5 studies | 31% ± 9% | |
retinal bipolar neuron | 4 studies | 26% ± 4% | |
astrocyte | 4 studies | 25% ± 5% | |
Mueller cell | 3 studies | 21% ± 2% | |
rod bipolar cell | 3 studies | 52% ± 4% | |
renal principal cell | 3 studies | 25% ± 5% |
Insufficient scRNA-seq data for expression of TBX2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 18477.35 | 578 / 578 | 80% | 12.09 | 927 / 1155 |
kidney | 100% | 7976.79 | 89 / 89 | 78% | 26.77 | 703 / 901 |
bladder | 100% | 7519.57 | 21 / 21 | 77% | 48.77 | 388 / 504 |
prostate | 100% | 4924.16 | 244 / 245 | 76% | 8.49 | 384 / 502 |
esophagus | 95% | 2556.99 | 1371 / 1445 | 77% | 10.37 | 140 / 183 |
skin | 68% | 1092.65 | 1228 / 1809 | 96% | 58.66 | 451 / 472 |
stomach | 97% | 2137.33 | 350 / 359 | 66% | 7.53 | 188 / 286 |
thymus | 100% | 3990.10 | 653 / 653 | 61% | 10.32 | 368 / 605 |
ovary | 81% | 2210.84 | 145 / 180 | 74% | 27.21 | 318 / 430 |
breast | 100% | 3637.88 | 459 / 459 | 53% | 5.03 | 588 / 1118 |
intestine | 89% | 2037.22 | 862 / 966 | 56% | 5.79 | 297 / 527 |
adrenal gland | 61% | 740.41 | 158 / 258 | 79% | 25.96 | 182 / 230 |
uterus | 100% | 4526.51 | 170 / 170 | 39% | 12.88 | 177 / 459 |
brain | 38% | 436.35 | 1005 / 2642 | 83% | 12.82 | 582 / 705 |
pancreas | 17% | 194.15 | 55 / 328 | 91% | 14.68 | 162 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 93.59 | 80 / 80 |
spleen | 100% | 4299.20 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 107.32 | 1 / 1 |
blood vessel | 100% | 8412.84 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 4309.09 | 1201 / 1204 | 0% | 0 | 0 / 0 |
heart | 95% | 2337.12 | 821 / 861 | 0% | 0 | 0 / 0 |
liver | 47% | 572.56 | 107 / 226 | 48% | 5.21 | 194 / 406 |
muscle | 65% | 796.32 | 522 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 18% | 2.60 | 8 / 45 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.84 | 4 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0060037 | Biological process | pharyngeal system development |
GO_1901211 | Biological process | negative regulation of cardiac chamber formation |
GO_0003151 | Biological process | outflow tract morphogenesis |
GO_0003148 | Biological process | outflow tract septum morphogenesis |
GO_0001708 | Biological process | cell fate specification |
GO_0060560 | Biological process | developmental growth involved in morphogenesis |
GO_0071549 | Biological process | cellular response to dexamethasone stimulus |
GO_0007219 | Biological process | Notch signaling pathway |
GO_0048596 | Biological process | embryonic camera-type eye morphogenesis |
GO_1902808 | Biological process | positive regulation of cell cycle G1/S phase transition |
GO_0003272 | Biological process | endocardial cushion formation |
GO_0060045 | Biological process | positive regulation of cardiac muscle cell proliferation |
GO_0001947 | Biological process | heart looping |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_1901208 | Biological process | negative regulation of heart looping |
GO_0042733 | Biological process | embryonic digit morphogenesis |
GO_0060441 | Biological process | epithelial tube branching involved in lung morphogenesis |
GO_0008543 | Biological process | fibroblast growth factor receptor signaling pathway |
GO_1905222 | Biological process | atrioventricular canal morphogenesis |
GO_0003203 | Biological process | endocardial cushion morphogenesis |
GO_1905072 | Biological process | cardiac jelly development |
GO_0072105 | Biological process | ureteric peristalsis |
GO_0090103 | Biological process | cochlea morphogenesis |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0007521 | Biological process | muscle cell fate determination |
GO_0043474 | Biological process | pigment metabolic process involved in pigmentation |
GO_0060021 | Biological process | roof of mouth development |
GO_0022008 | Biological process | neurogenesis |
GO_0060596 | Biological process | mammary placode formation |
GO_0035050 | Biological process | embryonic heart tube development |
GO_0051145 | Biological process | smooth muscle cell differentiation |
GO_0035909 | Biological process | aorta morphogenesis |
GO_0060379 | Biological process | cardiac muscle cell myoblast differentiation |
GO_0036302 | Biological process | atrioventricular canal development |
GO_0060916 | Biological process | mesenchymal cell proliferation involved in lung development |
GO_0048738 | Biological process | cardiac muscle tissue development |
GO_0006915 | Biological process | apoptotic process |
GO_0032526 | Biological process | response to retinoic acid |
GO_0090398 | Biological process | cellular senescence |
GO_0097325 | Biological process | melanocyte proliferation |
GO_0008016 | Biological process | regulation of heart contraction |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_2000773 | Biological process | negative regulation of cellular senescence |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | TBX2 |
Protein name | T-box transcription factor TBX2 (T-box protein 2) T-box transcription factor 2 |
Synonyms | |
Description | FUNCTION: Transcription factor which acts as a transcriptional repressor . May also function as a transcriptional activator (By similarity). Binds to the palindromic T site 5'-TTCACACCTAGGTGTGAA-3' DNA sequence, or a half-site, which are present in the regulatory region of several genes . Required for cardiac atrioventricular canal formation . May cooperate with NKX2.5 to negatively modulate expression of NPPA/ANF in the atrioventricular canal (By similarity). May play a role as a positive regulator of TGFB2 expression, perhaps acting in concert with GATA4 in the developing outflow tract myocardium (By similarity). Plays a role in limb pattern formation . Acts as a transcriptional repressor of ADAM10 gene expression, perhaps in concert with histone deacetylase HDAC1 as cofactor . Involved in branching morphogenesis in both developing lungs and adult mammary glands, via negative modulation of target genes; acting redundantly with TBX3 (By similarity). Required, together with TBX3, to maintain cell proliferation in the embryonic lung mesenchyme; perhaps acting downstream of SHH, BMP and TGFbeta signaling (By similarity). Involved in modulating early inner ear development, acting independently of, and also redundantly with TBX3, in different subregions of the developing ear (By similarity). Acts as a negative regulator of PML function in cellular senescence . Acts as a negative regulator of expression of CDKN1A/p21, IL33 and CCN4; repression of CDKN1A is enhanced in response to UV-induced stress, perhaps as a result of phosphorylation by p38 MAPK (By similarity). Negatively modulates expression of CDKN2A/p14ARF and CDH1/E-cadherin . Plays a role in induction of the epithelial-mesenchymal transition (EMT) . Plays a role in melanocyte proliferation, perhaps via regulation of cyclin CCND1 (By similarity). Involved in melanogenesis, acting via negative modulation of expression of DHICA oxidase/TYRP1 and P protein/OCA2 (By similarity). Involved in regulating retinal pigment epithelium (RPE) cell proliferation, perhaps via negatively modulating transcription of the transcription factor CEBPD . . |
Accessions | ENST00000240328.4 ENST00000419047.5 Q13207 F8WCM9 |